SciCross is part of the “Biomedical AI-driven data analytics” (BIO-AID) part of this 51 million sek research funding. https://t.co/qqoz33LFP7 (in Swedish only)
New paper on immunogenicity risk in MS patients treated with Interferon beta published in JCI Insight, https://t.co/4kbBpNK78T. #immunogenicity#MS#ABIRISK
New publication on on protein de-immunization, together with Harvard Medical school and the University of Tubingen.
#immunogenicity#FVIII#computationalimmunology
https://t.co/rpPnPUtO8h